541304 — Indo US Bio-Tech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Indo US Bio-Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2	1.32	0.492	1.9	11
Net Total Accounts Receivable
Net Total Receivables	225	261	234	328	202
Total Inventory
Total Other Current Assets
Total Current Assets	319	381	468	599	731
Net Property, Plant And Equipment	26.8	43.2	78.8	87.3	105
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	347	437	556	695	845
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	170	180	123	123	175
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	183	221	171	150	217
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	164	215	385	545	627
Total Liabilities & Shareholders' Equity	347	437	556	695	845
Total Common Shares Outstanding